Vigenent biomedical park investment project approved

2010-02-09

The application by Vigenent Biotechnology Co., Ltd., the company’s wholly owned subsidiary, for an investment project in the Biomedical Park of Hsinchu Science Park was approved at the 103rd meeting of the Science Park Review Committee of the National Science Council, Executive Yuan.

Back to news